A Study of the Mechanisms Behind Nociceptive Desensitization Caused by Topical Capsaicin
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Capsaicin (Primary) ; Histamine; Lidocaine
- Indications Diabetic neuropathies; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacodynamics; Therapeutic Use
- 18 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2018 Status changed from not yet recruiting to recruiting.
- 18 Jul 2018 New trial record